Sozinibercept
Product Specifications
CAS Number
2568358-31-4
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis
Bioactivity
Sozinibercept (OPT 302; VGX-300) is a soluble form of Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) that potently inhibits the activity of Vascular Endothelial Growth Factor-C and -D (VEGF-C/D), key proangiogenic factors involved in promoting angiogenesis and vascular leakage. Additionally, Sozinibercept has been shown to inhibit diabetic retinal edema in rats [1] [2] [3].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
028931-01 48 Tests
Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) BioAssayTM ELISA Kit (Rat) discontinued
Ask
View Details 
028931-02 96 Tests
Wingless Type MMTV Integration Site Family, Member 3A (WNT3A) BioAssayTM ELISA Kit (Rat) discontinued
Ask
View Details MBS1420857-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus Transcriptional regulatory protein srrA (srrA)
Ask
View Details MBS1420857-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus Transcriptional regulatory protein srrA (srrA)
Ask
View Details MBS1420857-03 0.02 mg (Yeast)
Recombinant Staphylococcus aureus Transcriptional regulatory protein srrA (srrA)
Ask
View Details